|
|
| | BIBP 3226 Basic information |
| Product Name: | BIBP 3226 | | Synonyms: | BIBP 3226 trifluoroacetate;N-[(1R)]-4-[(Aminoiminomethyl)amino-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl-α-phenylbenzeneacetamidetrifluoroacetate;Benzeneacetamide, N-[(1R)-4-[(aminoiminomethyl)amino]-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl]-α-phenyl-;(2R)-5-(diaminomethylideneamino)-2-[(2,2-diphenylacetyl)amino]-N-[(4-hydroxyphenyl)methyl]pentanamide;BIBP 3226 trifluoroa;BIBP3226 trifluoroacetate salt Diphenylacetyl-D-Arg-4-hydroxybenzylamide trifluoroacetate salt | | CAS: | 159013-54-4 | | MF: | C27H31N5O3 | | MW: | 473.57 | | EINECS: | | | Product Categories: | | | Mol File: | 159013-54-4.mol |  |
| | BIBP 3226 Chemical Properties |
| density | 1.24±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | H2O: 1 mg/mL | | form | A solid | | pka | 9.71±0.15(Predicted) |
| | BIBP 3226 Usage And Synthesis |
| Biological Activity | Mixed non-peptide neuropeptide Y Y 1 (NPY Y 1 ) and neuropeptide FF (NPFF) receptor antagonist (K i values are 1.1, 79, 108, > 1000, > 1000 and >1000 for rNPY Y 1 , hNPFF 2 , rNPFF, rNPY Y 2 , rNPY Y 4 and rNPY Y 5 respectively). Produces an anxiogenic-like effect in rats following i.c.v. administration. | | Biochem/physiol Actions | Selective non-peptide neuropeptide Y1 (NPY1) receptor antagonist. |
| | BIBP 3226 Preparation Products And Raw materials |
|